pharma · Malaria · Pharmacokinetics · CNSP
CNS Pharmaceuticals
CNS Pharmaceuticals is a pharma organization headquartered in Houston, USA. It trades on NYSE under ticker CNSP. Primary therapeutic focus areas include Malaria, Pharmacokinetics, Ovarian Cancer, Glioblastoma multiforme
Company details
- Status
- Public
- HQ
- Houston, TX 77027, US
- Founded
- 2017
- Employees
- 12
- Programs
- 21
- Drugs
- 18
- Patents
- 0
Quick answer
CNS Pharmaceuticals is a pharma organization headquartered in Houston, USA. It trades on NYSE under ticker CNSP. Primary therapeutic focus areas include Malaria, Pharmacokinetics, Ovarian Cancer, Glioblastoma multiforme (GBM), Glioblastoma Multiforme, Adult. NovaPharmaNews links 21 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 2 (11), phase 1 (9), phase 3 (1).
Company snapshot
CNS Pharmaceuticals is a biotechnology company focused on developing innovative therapies for serious diseases in neurology and oncology. With an experienced executive team and a focus on high-value therapeutic opportunities, the Company is working to build a differentiated portfolio of therapies addressing significant unmet medical needs. CNS Pharmaceuticals is committed to advancing novel treatm
- 21 active pipeline program(s) linked via ClinicalTrials.gov.
- 21 trial update(s) in the last 12 months.
Public regulatory, clinical, patent, and corporate records for CNS Pharmaceuticals. Not investment advice.
Top assets
Lead pipeline drugs
- Marketed / approved
- approved
- Marketed / approved
- Marketed / approved
Active clinical programs
- Phase 3
- Phase 2
- Phase 2
- Phase 2
Momentum
Proprietary activity score for CNS Pharmaceuticals.
1 active signal
Signal breakdown
- Clinical trials
- Nova articles
- Patents filed
- FDA actions
- SEC filings
- Conference presentations
- Pipeline advances
Competitor landscape
Therapeutic-area overlap peers from registry and pipeline signals.
- Peer + 0 momentum
- Peer + 0 momentum
- Peer + 0 momentum
- Peer + 0 momentum
Recent activity
Latest pipeline, patent, and corporate events for CNS Pharmaceuticals.
- Clinical update
- Clinical update
- Clinical update
- Clinical update
- Clinical update
Quick answers
Common questions about this sponsor — for analysts and search.
-
What is CNS Pharmaceuticals?
-
Is CNS Pharmaceuticals publicly traded?
-
What drugs does CNS Pharmaceuticals develop or market?
-
What are the latest developments for CNS Pharmaceuticals?
-
What therapeutic areas does CNS Pharmaceuticals focus on?
Therapeutic focus
Therapeutic area distribution
Pipeline concentration by therapeutic area from linked clinical programs.